Baricitinib (Olumiant) would be the first JAK inhibitor (and oral medicine) indicated for adults with moderate-to-severe atopic dermatitis who are candidates for systemic therapy. International Approvals …read more
The agency instructed states to submit plans for vaccine distribution by October 16, but an advisory committee member suggested that the deadline may be premature. Medscape Medical News …read more
These findings underscore concerns about the use of opioids in this population as they demonstrate a significantly increased risk of ‘multiple preventable serious adverse drug events.’ Medscape Medical News …read more
Time spent in normal thyroid range over 3 years was the same whether patients took levothyroxine or desiccated thyroid; editorial says keeping the latter in the treatment tool kit is important. Medscape Medical News …read more